Home › NDC Lookup › Ingredients › Neomycin Sulfate › 00924-5620-01
First Aid Only Neomycin Antibiotic neomycin sulfate 3.5 mg/g Ointment, 10 pouches — NDC 00924-5620-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

First Aid Only Neomycin Antibiotic neomycin sulfate 3.5 mg/g Ointment, 10 pouches — NDC 0924-5620-01 (Billing 00924-5620-01)

by Acme United Corporation · 10 POUCH in 1 BOX / .9 g in 1 POUCH

This is a package of 10 pouches of First Aid Only Neomycin Antibiotic neomycin sulfate 3.5 mg/g Ointment from Acme United Corporation, marketed since Jul 2021 and currently FDA-listed.

NDC 00924-5620-01
🏷️ FDA NDC (as labeled) 0924-5620-01 billing pads the labeler segment with a zero
This package
Contains10 pouches Pack sizes3 compare ↓
Product page 00924-5620-00 Also comes in: 9 g 0924-5620-00 20 pouches 0924-5620-02
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0924-5620-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0924 labeler · 5620 product · 01 package
Package marketed since
May 10, 2023
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 0924562001 2
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0924-5620-01
Product NDC 0924-5620
11-digit billing NDC 00924562001
RxCUI 311928
UNII 057Y626693
Application # M004
SPL Set ID c651e98e-aabe-de46-e053-2a95a90a6307
Established class (EPC) Aminoglycoside Antibacterial
Chemical class Aminoglycosides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-07-16
Route TOPICAL
Dosage form OINTMENT
Substance NEOMYCIN SULFATE
Quick answers
  • RxCUI (RxNorm): 311928
Why two NDCs? The FDA registers this code as 0924-5620-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00924-5620-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Aminoglycoside Antibacterial class.

Pharmacologic class Aminoglycoside Antibacterial
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Antibiotics, Antiinfectives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Neomycin, an antibiotic, is used to prevent or treat skin infections caused by bacteria. It is not effective against fungal or viral infections. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It's a first-aid antibiotic you put directly on the skin to help prevent infection in minor cuts, scrapes, and small burns. It's not meant for serious wounds or large areas of the...
  • Apply it directly to the affected area of skin. Follow the directions on your specific product label for how often to use it. As a general rule, don't use it for more than one week...
  • The main thing to watch for is a rash or any sign of an allergic reaction — like increased redness, swelling, or itching at or near the application site. If that happens, stop usin...
  • What should I watch out for while using it?
📖 Read our full Neomycin Topical guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
10
Nutrient depletion considerations

Neomycin may be associated with lower levels of 10 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Neomycin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 9 g 20 pouches
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00924-5620-00 0924-5620-00 Main listing .9 g in 1 POUCH 2021-07-16 — Active
00924-5620-01 You're viewing this 10 POUCH in 1 BOX / .9 g in 1 POUCH 2023-05-10 — Active
00924-5620-02 0924-5620-02 20 POUCH in 1 BOX / .9 g in 1 POUCH 2023-05-10 — Active

Pack size FAQ

What quantity is in this package?
This package contains 10 pouches — 10 pouch in 1 box / .9 g in 1 pouch.
How does this package differ from NDC 00924-5620-00?
Both are First Aid Only Neomycin Antibiotic neomycin sulfate 3.5 mg/g Ointment — the drug itself is identical. This page's package is the 10 pouches one, while NDC 00924-5620-00 is the 9 g package.
What NDC number is used to bill for this package of First Aid Only Neomycin Antibiotic neomycin sulfate 3.5 mg/g Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
First Aid Only Neomycin Antibiotic 3.5 mg/gthis 00924-5620-01 Acme 10 pouches — — FDA listed —
Pomada de Sulfa 3.5 mg/g 53145-0056-02 Menper 1 jar — — FDA listed —
Antibiotic 3.5 mg/g 55550-0730-21 Total 9 g — — FDA listed —
Water-Jel Neomycin Antibiotic 3.5 mg/g 59898-0730-01 Water-Jel 1728 packets — — FDA listed —
Single Antibiotic with Neomycin 3.5 mg/g 61010-6700-02 Safetec 144 pouches — — FDA listed —
Vitacilina Neomycin Sulfate First Aid Antibiotic 3.5 mg/g 54312-0019-31 Compania 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Jul 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Neomycin Topical inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesmineral oil, petrolatum

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAcme United Corporation
FDA applicationM004 (OTC MONOGRAPH DRUG)
Labeler code00924
First marketedJul 2021
Product typeHuman Otc Drug
Portfolio59 products on file

More NDCs from Acme United Corporation labeler code 00924

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 26 words ▾

Uses: First aid to help prevent infection in minor cuts, scrapes, burns.

Use firstaid to help prevent infection in minor • scrapes • cuts • burns

⏱️ Dosage and Administration 18 words ▾

Directions clean affected area apply small amount 1 to 3 times daily may cover with a sterile bandage

⚠️ Warnings 78 words ▾

Warnings: For external use only. Keep out of reach of children . If swallowed, contact a Poison Control Center right away Do Not Use: in the eyes • over large areas of the body • on puncture wounds, animal bites or serious burns longer than 1 week unless directed by a doctor if you are allergic to any of the ingredients Stop use, ask a doctor if a rash or allergic reaction develop condition persists or gets worse

🧪 Active Ingredient 10 words ▾

Active Ingredient (in each gram) Neomycin Sulfate (3.5 mg Neomycin)

🧪 Inactive Ingredients 6 words ▾

Inactive ingredients : mineral oil, petrolatum

🎯 Purpose 16 words ▾

Purpose First Aid Antibiotic Uses: First aid to help prevent infection in minor cuts, scrapes, burns.

📄 Do Not Use 40 words ▾

Do Not Use: in the eyes • over large areas of the body • on puncture wounds, animal bites or serious burns longer than 1 week unless directed by a doctor if you are allergic to any of the ingredients

📄 Stop Use and Ask a Doctor If 17 words ▾

Stop use, ask a doctor if a rash or allergic reaction develop condition persists or gets worse

📄 Keep Out of Reach of Children 16 words ▾

Keep out of reach of children . If swallowed, contact a Poison Control Center right away

📄 Package Label / Principal Display Panel 4 words ▾

Pouch Label Pouch Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Neomycin Sulfate (matched by generic name) — the program that covers self-administered drugs. 3 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Neomycin Sulfate. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$282K
Claims incl. refills
26.7K
Beneficiaries
25.4K
Spend / beneficiary
$11.11
Spend / claim
$10.55
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Neomycin sulfate — the ingredient across all brands.

Top reported reactions

Drug Hypersensitivity573
Pain464
Dyspnoea386
Nausea386
Malaise336
Rash288
Headache265

Reporter sex

4,259 reports
Male · 29%
Female · 69%
Unknown · 1%

Serious outcomes

Hospitalization1,046
Death382
Disabling300
Life-threatening272
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 298 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Acme United Corporation. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 9 g (00924-5620-00), 20 pouches (00924-5620-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Acme United Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00924-5618-00 · Acme 00924-5633-00 · Acme →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.